These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15788579)
21. Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases. Georgakopoulos A; Pianou N; Kelekis N; Chatziioannou S Clin Imaging; 2013; 37(3):536-41. PubMed ID: 23116727 [TBL] [Abstract][Full Text] [Related]
23. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy. Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisions. Amthauer H; Denecke T; Hildebrandt B; Rühl R; Miersch A; Nicolaou A; Ruf J; Plotkin M; Hänninen EL; Stroszczynski C; Gutberlet M; Langrehr J; Riess H; Ricke J Nuklearmedizin; 2006; 45(4):177-84. PubMed ID: 16964344 [TBL] [Abstract][Full Text] [Related]
25. [Clinical value of (18)F-FDG positron emission tomography-computed tomography in local liver neoplasm ablation]. Liao WJ; Wu HB; Chen JZ; Shi M; You CX; Wang QS Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1641-2. PubMed ID: 19726317 [TBL] [Abstract][Full Text] [Related]
26. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Wiering B; Ruers TJ; Oyen WJ Expert Rev Anticancer Ther; 2004 Aug; 4(4):607-13. PubMed ID: 15270664 [TBL] [Abstract][Full Text] [Related]
27. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer]. Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351 [TBL] [Abstract][Full Text] [Related]
28. Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis. Schnitzer ML; Buchner J; Biechele G; Grawe F; Ingenerf M; von Münchhausen N; Kaiser CG; Kunz WG; Froelich MF; Schmid-Tannwald C; Rübenthaler J Eur J Radiol; 2023 Jun; 163():110803. PubMed ID: 37004464 [TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Truant S; Huglo D; Hebbar M; Ernst O; Steinling M; Pruvot FR Br J Surg; 2005 Mar; 92(3):362-9. PubMed ID: 15672427 [TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance. Schoellnast H; Larson SM; Nehmeh SA; Carrasquillo JA; Thornton RH; Solomon SB Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S182-5. PubMed ID: 20508937 [TBL] [Abstract][Full Text] [Related]
31. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging. Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223 [TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of 18F-FDE PET-CT in detecting malignant liver tumors]. Yao SZ; Zhang CQ; Chen J; Liu QW; Li QG Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1214-6. PubMed ID: 14625192 [TBL] [Abstract][Full Text] [Related]
33. [Malignant tumor with false negative 18F-FDG PET image]. Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383 [TBL] [Abstract][Full Text] [Related]
34. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736 [TBL] [Abstract][Full Text] [Related]
35. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
36. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557 [TBL] [Abstract][Full Text] [Related]
37. PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation. Nielsen K; van Tilborg AA; Scheffer HJ; Meijerink MR; de Lange-de Klerk ES; Meijer S; Comans EF; van den Tol MP Eur J Radiol; 2013 Dec; 82(12):2169-75. PubMed ID: 24021269 [TBL] [Abstract][Full Text] [Related]
40. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]